Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Big Beat for Pharmacyclics' (PCYC) Imbruvica - Baird
August 1, 2014 7:18 AM UTCBaird analyst Brian Skorney reiterated an Outperform rating and $173 price target on Pharmacyclics (NASDAQ: PCYC) following Q2 results with Imbruvica putting up a big beat.
"We believe the substantial top-line beat will result in broad increases in consensus estimates as well as a... More
WallachBeth Capital Upgrades Pharmacyclics (PCYC) to Buy
August 1, 2014 6:52 AM UTCWallachBeth Capital upgraded Pharmacyclics (NASDAQ: PCYC) from Hold to Buy.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $120.44 yesterday.
... More